Karen Major

Karen Major has over 20 years of experience in regulatory affairs. Karen currently serves as the Vice President Regulatory Affairs at Turnstone Biologics since August 2018. Prior to that, they were the Sr. Director- Regulatory Affairs at Turnstone Biologics from April 2017. Before joining Turnstone Biologics, they worked as the Sr. Director, Regulatory Affairs at Arbutus Biopharma Corporation from September 2013 to December 2016. Karen also held the position of Director, Regulatory Affairs at YM BioSciences from January 2011 to May 2013. From May 2006 to December 2010, they served as the Director, Global Regulatory Affairs at Viventia Biotech. Karen began their career as a Scientific and Regulatory Consultant at Cantox Health Sciences International from January 2001 to May 2006.

Karen Major has a strong educational background in scientific and regulatory affairs. Karen obtained a B.Sc. (Hon) in Pharmacology & Toxicology from the University of Toronto, where they studied from 1994 to 1999. In 2000, Karen attended Seneca College and earned a Diploma in Regulatory Affairs and Quality Operations.

In addition to their formal education, Karen has also obtained certifications to further enhance their expertise. In 2001, they became a member of the Regulatory Affairs Certification Program (RAPS). Later, in 2006, Karen achieved the RAC-US certification from the same institution.

Overall, Karen Major has pursued education and certifications in pharmacology, toxicology, and regulatory affairs, demonstrating their dedication to expertise in this field.